Individuals diagnosed with major depression have increased levels of pro-inflammatory cytokines and corresponding receptors in peripheral blood and cerebral spinal fluid25,26, and pro-inflammatory cytokines activate the p38 MAPK pathway, which subsequently can activate the serotonin transporter (SERT)27. The gene discussed is SLC6A4; the disease is major depressive disorder.